as on December 5, 2025 at 2:24 am IST
Day's Low
Day's High
1.21%
Downside
2.82%
Upside
52 Week's Low
52 Week's High
61.61%
Downside
266.13%
Upside
Check Tharimmune Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$83.1M
EPS (TTM)
-7.06
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-225.01%
Compare market cap, revenue, PE, and other key metrics of Tharimmune Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| $83.1M | NA | NA | 0.00% | ||
| BUY | $44.1B | 415.15% | -16.34 | -264.83% | |
| BUY | $61.4B | 265.31% | 1408.88 | 1.36% | |
| BUY | $111.1B | 102.84% | 29.93 | 31.35% | |
| BUY | $78.6B | 46.95% | 17.98 | 32.13% |
The Tharimmune Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Tharimmune Inc investment value today
Current value as on today
₹1,21,448
Returns
₹21,448
(+21.45%)
Returns from Tharimmune Inc Stock
₹15,349 (+15.35%)
Dollar Returns*
₹6,099 (+6.1%)
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Tharimmune Inc. Average target price of $5
Get share price movements and forecasts by analysts on Tharimmune Inc.
What analysts predicted
50.4%UPSIDE
Target Price
$5
Current Price
$2.48
Analyzed by
6 Analysts
Target
$5.00
Tharimmune Inc target price $5, a slight upside of 50.4% compared to current price of $2.48. According to 6 analysts rating.
Search interest for Tharimmune Inc Stock has increased by 493% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:493% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 03 November
Mon, 08:24 PM
-Tharimmune raises $540 million for Canton Coin treasury strategy, stock rises 30% on announcement.
Tue, 03:00 AM
-Tharimmune's stock gains 14% after announcing $540 million capital raise for Canton Coin acquisition.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 174.5% return, outperforming this stock by 151.8%
Price Dip
![]()
In the last 1 month, THAR stock has moved down by -37.6%
| Organisation | Tharimmune Inc |
| Headquarters | 34 Shrewsbury Avenue, Red Bank, NJ, United States, 07701 |
| CEO | Mr. Mark Wendland |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Sireesh Appajosyula Pharm.D. | Interim CFO & Director |
Mr. Vincent LoPriore | Executive Chairman of the Board |
Mr. Mark Wendland | Chief Executive Officer |
Mr. Mark Toomey | President |
Dr. Nir Barak M.D. | Chief Medical Advisor |
Tharimmune Inc share price today is $2.48 as on at the close of the market. Tharimmune Inc share today touched a day high of $2.55 and a low of $2.45.
Tharimmune Inc share touched a 52 week high of $9.08 on and a 52 week low of $0.95 on . Tharimmune Inc stock price today i.e. is closed at $2.48,which is 72.69% down from its 52 week high and 160.50% up from its 52 week low.
Tharimmune Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Tharimmune Inc (THAR) shares with as little as ₹89.888 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.88 in Tharimmune Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Tharimmune Inc share’s latest price of $2.48 as on December 5, 2025 at 2:24 am IST, you will get 4.0323 shares of Tharimmune Inc. Learn more about
fractional shares .